Company profile: Excelimmune
1.1 - Company Overview
Company description
- Provider of fully human recombinant polyclonal antibodies for therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Excelimmune
Chembio Diagnostics
HQ: United States
Website
- Description: Provider of proprietary rapid point-of-care diagnostic tests, developing, manufacturing, licensing and marketing DPP assays for HIV 1/2, HIV-Syphilis, Zika (IgM/IgG in Europe; IgM in the USA), Ebola antigen (USA), and Zika-Chikungunya-Dengue (Europe). Portfolio includes two FDA PMA-approved, CLIA-waived rapid HIV tests marketed in the U.S. by Alere (formerly Inverness Medical Innovations).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chembio Diagnostics company profile →
Kramer Labs
HQ: United States
Website
- Description: Provider of branded over-the-counter medicines in the foot care and cough-cold segments of the consumer healthcare market, offering products such as Nizoral A-D Anti-Dandruff Shampoo, Opti-Nail Fungal Nail Repair Pen, Kaopectate Diarrhea & Upset Stomach Reliever, Colace Stool Softener, Senokot laxatives, and NATURELO premium supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kramer Labs company profile →
Cerus
HQ: United States
Website
- Description: Provider of blood safety pathogen reduction systems: INTERCEPT Blood System for Platelets and Plasma (available globally with regulatory approvals); INTERCEPT Red Blood Cell System (under regulatory review in Europe and in late-stage clinical development in the US); INTERCEPT Blood System of Cryoprecipitation to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex to treat and control bleeding associated with fibrinogen deficiency.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cerus company profile →
MaxThera
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development of new treatments for bacterial infections, especially those caused by drug-resistant bacteria.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full MaxThera company profile →
Trillium Diagnostics
HQ: United States
Website
- Description: Provider of cellular diagnostics offering insight into human disease as a healthcare center.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Trillium Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Excelimmune
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Excelimmune
2.2 - Growth funds investing in similar companies to Excelimmune
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Excelimmune
4.2 - Public trading comparable groups for Excelimmune
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →